跳至主要内容
临床试验/NCT01542710
NCT01542710已完成不适用

Bimatoprost/Timolol Versus Travoprost/Timolol Fixed Combinations in an Egyptian Population: A Hospital-Based Prospective Randomized Study

Kasr El Aini Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2011年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80
试验地点
1
主要终点
Percentage of drop of intraocular pressures from baseline.

研究概览

简要总结

The purpose of this study is to compare 2 fixed combination medications in intraocular pressure lowering.

详细描述

PURPOSE: To compare the efficacy of bimatoprost/timolol (BTFC) or travoprost/timolol (TTFC) fixed combinations on intraocular pressure (IOP) reduction in an Egyptian population.

METHODS: Patients with primary open angle glaucoma (POAG) were randomized to receive either BTFC or TTFC. IOPs were measured at baseline, 2 weeks, and 1, 2, 4, and 6 months. The primary outcome measures were the mean change in IOP from baseline

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • No other ocular diseases

研究组 & 干预措施

Glaucoma fixed Combination Medications

Experimental

干预措施: Ganfort (Drug)

Glaucoma fixed Combination Medications

Experimental

干预措施: Duotrav (Drug)

结局指标

主要结局

Percentage of drop of intraocular pressures from baseline.

时间窗: 1 year

次要结局

未报告次要终点

研究者

发起方
Kasr El Aini Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Tamer A Macky

Assistant Professor

Kasr El Aini Hospital

研究点 (1)

Loading locations...

相似试验